Summary：SpaceX Shares Fall Below IPO Level, Investors Worry About Future Growth **Introduction** SpaceX’s

referrerpolicy="no-referrer"
style="max-width:100%;height:auto;display:block;margin:0 auto;">

SpaceX Shares Fall Below IPO Level, Investors Worry About Future Growth

**Introduction**
SpaceX’s stock slipped beneath its initial public offering price for the first time on Wednesday, marking a fourth consecutive day of losses. The share price dipped to $132.15, undercutting the $135 IPO level set just a month ago, according to the Wall Street Journal. The decline has sparked fresh debate among analysts about whether the company’s lofty growth narrative can withstand near‑term market pressures.

**Key Developments**
The sell‑off began after SpaceX reported weaker‑than‑expected quarterly revenue from its Starlink satellite‑internet service, citing slower subscriber uptake in Europe and regulatory hurdles in several emerging markets. Simultaneously, the firm announced a delay in the next Starship test flight, pushing the schedule from late summer to early 2026. Investors reacted sharply, pushing the stock down roughly 2.3% on the day and erasing about $4 billion in market capitalization. Trading volume spiked to 1.8 million shares, well above the 30‑day average, indicating heightened anxiety among both retail and institutional holders.

**Industry Analysis**
Aerospace analysts note that SpaceX’s valuation has always relied on a blend of disruptive technology and aggressive growth forecasts. The recent dip suggests the market is recalibrating those expectations. While the company’s launch business remains robust—evidenced by a backlog of over 70 missions valued at $10 billion—its newer ventures, particularly Starlink, face intensifying competition from rival constellations such as OneWeb and Kuiper. Moreover, macro‑economic headwinds, including rising interest rates and a cautious stance toward high‑growth equities, have amplified sensitivity to any earnings miss. Some experts argue that the current price correction may be healthy, bringing the stock closer to a more sustainable earnings‑multiple range rather than signaling fundamental weakness.

**Future Outlook**
Looking ahead,